The use of multiple drugs by patients increases the risk of medical problems. Clinical decision-support could assist general practitioners (GPs) with prescribing, but is underused. This paper aims to investigate the attitudes of GPs towards using decision-support systems. A survey was distributed amongst 500 Dutch GPs. Virtually all 184 respondents indicated owning a clinical information system, while only 21% indicated owning a decision-support plug-in; this had moderate influence on their use of medical formularies. Only use of one of the medical formularies positively influenced the number of recognized underprescription problems. GPs' attitudes towards a newly proposed system aiding them with polypharmacy prescribing were mainly positive (57%); the perceived usefulness was influenced by output quality (p=.000), time investment (p=.000), and financial stimuli (payability p=.000, reimbursement p=.015), but not by job relevance. The results of this study confirm the consensus in literature that decision-support systems improve GPs' quality of prescriptions.
Introduction
In the past decade the development of decisionsupport systems for the primary health care sector has greatly increased. Whether The primary care area of polypharmacy, occupied with the use of multiple medications by a patient, suffers from suboptimal prescribing. In the Netherlands alone, seventeen percent of the chronically ill use more than five different drugs permanently; half of these patients are over seventy years of age (8) . This polypharmacy is associated with medical problems including an increasing risk of adverse effects, under-prescribing, overtreatment, and decreased drug adherence (9, 10, 11, 12, 13, 14, 15, 16) .
Many of these problems are due to avoidable human errors GPs make during the prescribing process, including use of incomplete patient information, insufficient communication, and mistakes because of time pressure or carelessness (17, 18) .
To counter these problems, the Prescribing Optimization Method was designed, a step-by-step method to aid GPs in optimizing drug prescriptions.
In tests, this method significantly improved their prescriptions' quality and relevance (19) . In order to fully enable the use of the method, the POM Platform (POMP) has been envisioned: a decisionsupport knowledge system that facilitates the POM and is optimally incorporated into GPs' systems and workflows.
Recognizing the aforementioned problems regarding technology adoption by GPs, it is essential to investigate these issues in the Dutch primary care sector, in order to incorporate the results in the realization phases. Therefore the focus of this paper is to explore these issues by assessing the current use of decision-support systems and by examining Jongste, Overbeek et al. (21) showed that the system they tested "changed the manners in which the physicians monitored their patients and, to a lesser extent, their treatment behavior."
Due to these developments, CPOE software in the primary care sector has increased in diversity in recent years. From systems that were mostly organizational in nature, they have been enhanced to facilitate consultation of electronic medical records and clinical decision support (22).
Software Market Diversity
Consequently, the Dutch software market of GPs' CPOE systems is diverse. Up to ten different systems are currently in use, all providing their own distinct features and tools in addition to the common patient record management facilities (22) . Some of these systems include their own digital prescription aids and decision-support tools, while others do not.
As a result, third-party developers have produced additional software that, integrated with their existing systems, assists GPs in prescribing drugs.
The major plug-ins on the market are Prescriptor, which can communicate with most existing GPs' CPOE systems, and NHGDoc, which currently has limited integration capabilities (23, 24) .
POMP
The Prescribing Optimization Method Platform (POMP) has been envisioned as a software program that, integrated with these aforementioned CPOE systems, would add to GPs' range of assistive tools.
Through the decision-support platform, GPs would be advised on how to prescribe in patient-specific cases; through a medication review structured by the Polypharmacy Optimization Method they would determine actual use of drugs, identify superfluous ones, and detect untreated diseases. Advice provided by the system would be based on proven clinical interactions between drugs, compatibility of medicine with patients' other diseases, and best practices extracted through knowledge management. The system would facilitate the execution of a medication review, and thus operate on-demand; it would not disturb GPs' workflows by reacting to decisions made during general consultations.
While the POM Platform will take the form of a stand-alone software program, it will be fully integrated in existing systems as far as user interaction and data exchange are concerned.
Through this means the developers seek to avoid the production of a software product that is underused or performs suboptimally.
Technology Adoption
The adoption of technology by potential users has been extensively studied and has led to the development of various predictive models, including the TAM, TAM2, and UTAUT (25, 26, 27 
Theoretical Framework
Based on the main technology adoption models and the deviations common in the aforementioned literature findings, a theoretical model for testing the attitudes of GPs in the Dutch primary care sector was assembled.
In Figure 1 
Hypotheses
Below the hypotheses that were tested in this study are listed. As will be explained in more detail in the section on Research Design, the hypotheses were tested for correlations, and thus they do not contain causality implications. The meaning of the data analysis will be elaborated on in the Discussion. 
Research Design

Method
A survey was deemed an appropriate method to examine potential users´ attitudes towards a system assisting them with polypharmacy prescribing.
Especially the fact that many potential users could be surveyed was a determinant factor. 
Validity
The internal validity of most of the survey's questions on technology adoption followed naturally 
Results
Research Group
The survey was sent by mail to five hundred practicing GPs, accompanied by a cover letter.
Potential respondents were invited to either fill out the survey online or return their copy by mail. The vast majority (98%) chose for the latter option.
184 GPs returned filled-out questionnaires, which made a response rate of 37%. Of these respondents, only 15% was younger than 40; 27% were in their forties, while 47% were in their fifties. 10% were sixty years or older, with only one respondent being over 65 years of age. 21% of the respondents worked alone, 37% shared their practice with one colleague, but the majority of 42% worked with several others. All but one of the surveyed GPs reported owning a professional information system; one was unsure.
Software Market Diversity
The earlier assumption regarding the diversity of the CPOE systems market was proven to be correct by the survey results. Two of the companies dominated the market, as they were used by 58% of the respondents (see Figure 2 ). Seven smaller manufacturers each had market shares between 1%
and 12%. 29% of the respondents indicating owning Prescriptor, while 25% was unsure of that; the remainder indicated not owning the product. Fewer respondents (13%) owned the comparable decisionsupport system NHGDoc, with an additional 26% being unsure. Of the respondents indicating owning one of these systems, the actual use differed. Of the owners of Prescriptor, the majority (55%) indicated using it never or rarely (less than once a week). 39% used it once or multiple times per consultation, with only 6% using it once per week. NHGDoc numbers were comparable; 54% used the software package rarely or never, 38% used it intensively, and 8% just once per week.
Decision-Support Systems & Medical Formularies
Statistical analysis showed that owners using one These results validated H4 in the above-mentioned cases. H2 and H3 were accepted for Prescriptor but not for NHGDoc, while H5 was rejected altogether.
Problem Recognition
The problems commonly associated with polypharmacy were widely recognized. 95% of 
Age
Finally, the hypotheses regarding the impact of respondents' ages on the constructs were tested. As 
Discussion
With this paper the authors aimed at exploring the motivations of GPs to adopt decision-support systems. This study being part of a greater project involving polypharmacy complications, the data collection focused on GPs' experiences with polypharmacy prescribing, treatment and assistive software.
The questionnaire's results showed that the Dutch market of GPs' CPOE systems is very diverse, even though the two largest providers control half of the market. Assistive plug-ins for these products are roughly distributed amongst a fourth of the GPs; their functionality, however, is seriously underused.
The majority of the owners of this assistive software indicate never or rarely ever using it, with just under forty percent employing it regularly during consultations.
Simultaneously, the results indicate that -in several cases -use of decision-support systems is related to use of medical formularies. Furthermore, in the case of the NHG-guidelines the adherence to these clinical rules is related to GPs' recognition of polypharmacy problems.
As mentioned earlier, the data analysis only revealed correlations between hypotheses; causality could not be inferred from the statistical results. However, since the hypotheses were based on the influential relations between the variables in Figure 1 , which in turn were based on consensus in literature, causality can be assumed when interpreting these results.
As for GPs' attitudes towards using an assistive software program aiding them with polypharmacy treatment, subjects generally responded positively to the idea of such a decision-support system. Some, The theoretical framework in Figure 1 includes two constructs that are commonly included in technology adoption models; job relevance and output quality. Of these, the only one that appears to be strongly valued by GPs is that of output quality.
The other construct, job relevance, seems to be of lesser importance; neither the number of patients suffering from polypharmacy a GP treats seems to positively influence his or her opinion towards the proposed system, nor does the (number of) recognized problems. This finding does not concur with GPs' answers regarding the system's usefulness, nor does it reflect views in literature that specifically mention job relevance as vital to GPs' attitudes (30) .
Reasons for this discrepancy may be found in the methodical approach to this aspect, which will be further elaborated upon in the section on
limitations. 
Limitations
Even though utmost care was taken in the conduction of this study in order to ensure its reliability and validity, some considerations should be taken into account when applying its findings.
The survey employed in the study contained some questions that did not directly represent theoretical constructs, most notably the one on job relevance.
This choice was made because of the possible ambiguity respondents may perceive between that concept and usefulness, but ultimately it hinders generalizability. The large differences between the rough estimates given by the respondents may explain the lack of significance in the relations measured. Considering that this study's outcomes on job relevance do not concur with scientific consensus, the authors suggest that these specific findings should be generalized outside of this study with reservation.
Additionally, given that respondents voluntarily participated in the study, they may be more interested in, and thus hold more positive attitudes towards, clinical decision-support systems than nonparticipants.
Further Research
This study has investigated factors of influence on 
